Tennessee
(State
or other jurisdiction
of
incorporation)
|
|
001-15875
(Commission
File
Number)
|
|
54-1684963
(IRS
Employer
Identification
Number)
|
501
Fifth Street, Bristol, Tennessee
(Address
of principal executive offices)
|
|
37620
(Zip
Code)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
(d) |
Exhibits:
|
Exhibit
Number
|
Description
of Exhibit
|
99.1
|
Press
release issued by King Pharmaceuticals, Inc. dated August 9,
2006.
|
Date:
August 9, 2006
|
KING
PHARMACEUTICALS, INC.
|
|
By:
|
/s/
Brian A. Markison
Brian
A. Markison
President
and Chief Executive Officer
|